BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2806210
Number of visits today
1288
Number of downloads
2058662
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang L, Xiong H, Li X, Li Y, Zhou H, Lin X, Chan TF, Li R, Lai KP, Chen X. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19. Front Nutr 2022;9:870370. [DOI: 10.3389/fnut.2022.870370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Wang S, Hong Y, Gai R, Hong W, Tang B, Lin C, Wang X, Wang Q, Chen C, Wang J, Weng Q. Safety Evaluation of Curcumol by a Repeated Dose 28-Day Oral Exposure Toxicity Study in Rats. Toxics 2023;11. [PMID: 36850989 DOI: 10.3390/toxics11020114] [Reference Citation Analysis]
2 Tian Y, Yu B, Zhang Y, Zhang S, lv B, Gong S, Li J. Exploration of the potentially common pathogenic mechanisms in COVID-19 and silicosis using bioinformatics and system biology.. [DOI: 10.21203/rs.3.rs-2467274/v1] [Reference Citation Analysis]
3 Sarker B, Rahaman MM, Islam MA, Alamin MH, Husain MM, Ferdousi F, Ahsan MA, Mollah MNH. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections. PLoS One 2023;18:e0281981. [PMID: 36913345 DOI: 10.1371/journal.pone.0281981] [Reference Citation Analysis]
4 Dong Q, Yang S, Liao H, He Q, Xiao J. Preclinical findings reveal the pharmacological targets of ferulic acid in the treatment of traumatic brain injury. Food Science & Nutrition 2022;10:4403-4410. [DOI: 10.1002/fsn3.3036] [Reference Citation Analysis]
5 Li J, Peng P, Lai KP. Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma. Front Nutr 2022;9:961697. [PMID: 35967794 DOI: 10.3389/fnut.2022.961697] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345